MassMutual Private Wealth & Trust’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.29K Hold
1,460
﹤0.01% 1482
2026
Q1
$6.26K Buy
1,460
+490
+51% +$2.73K ﹤0.01% 1574
2025
Q4
$8.69K Sell
970
-360
-27% -$2.23K ﹤0.01% 1448
2025
Q3
$4.92K Buy
1,330
+360
+37% +$981 ﹤0.01% 1677
2025
Q2
$1.89K Buy
970
+169
+21% +$352 ﹤0.01% 1963
2025
Q1
$1.41K Buy
+801
New +$1.82K ﹤0.01% 2027
2023
Q3
Sell
-185
Closed -$333 2019
2023
Q2
$333 Buy
185
+24
+15% +$41 ﹤0.01% 1827
2023
Q1
$267 Hold
161
﹤0.01% 1754
2022
Q4
$0 Sell
161
-500
-76% -$1.01K ﹤0.01% 1780
2022
Q3
$1K Buy
+661
New +$1.89K ﹤0.01% 1469

Other funds holding NUVB

MassMutual Private Wealth & Trust's NUVB Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Nuvation Bio (NUVB) position steady in Q2 2026 at 1,460 shares worth $8.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

MassMutual Private Wealth & Trust first reported a position in NUVB in Q3 2022 and has held it in 10 quarters since. The position peaked at $8.69K in Q4 2025. 46 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • MassMutual Private Wealth & Trust held 1,460 shares of Nuvation Bio worth $8.29K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1482 holding.
  • MassMutual Private Wealth & Trust first reported a position in Nuvation Bio in Q3 2022 and has held it in 10 quarters since.
  • MassMutual Private Wealth & Trust's Nuvation Bio position peaked at $8.69K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.